首站-论文投稿智能助手
典型文献
Case report of a mixed pulmonary large cell neuroendocrine carcinoma
文献摘要:
A 57 year-old male patient was found to have a lesion in the middle lobe of his right lung using chest computed tomography (CT). Tumor cells were detected, and surgical excision was performed. The patient was diagnosed with mixed large cell neuroendocrine carcinoma, and underwent six cycles of a chemotherapy regimen comprising etoposide combined with cisplatin. Genetic testing revealed an EGFR mutation, which prompted oxitinib-targeted therapy. To date, no signs of recurrence or metastasis have been reported.
文献关键词:
作者姓名:
Xiaoying Quan;Xiaoyan Chen;Lei Lei;Xiaoli Jia;Chunzhi Wu;Bin Ye
作者机构:
Department of Medical Oncology,The Sixth People's Hospital of Chengdu,Chengdu 610051,China
引用格式:
[1]Xiaoying Quan;Xiaoyan Chen;Lei Lei;Xiaoli Jia;Chunzhi Wu;Bin Ye-.Case report of a mixed pulmonary large cell neuroendocrine carcinoma)[J].肿瘤学与转化医学(英文),2022(06):311-313
A类:
oxitinib
B类:
Case,mixed,pulmonary,large,neuroendocrine,carcinoma,year,old,male,patient,was,found,have,lesion,middle,lobe,his,right,lung,using,chest,computed,tomography,Tumor,cells,were,detected,surgical,excision,performed,diagnosed,underwent,six,cycles,chemotherapy,regimen,comprising,etoposide,combined,cisplatin,Genetic,testing,revealed,EGFR,mutation,which,prompted,targeted,To,date,signs,recurrence,metastasis,been,reported
AB值:
0.738561
相似文献
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID?19 in a Han Chinese population from Central China
Yi Wu;Xian‑Hui Wang;Xi‑Hua Li;Li‑Yuan Song;Shi‑Long Yu;Zhi‑Cheng Fang;Yu‑Quan Liu;Le‑Yong Yuan;Chun‑Yan Peng;Shen‑Yi Zhang;Wang Cheng;Hong‑Chao Ma;Li‑Feng Wang;Jun‑Ming Tang;Yun‑Fu Wang;Fu‑Yun Ji-Department of Medical Biology,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Biomedical Research,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Human Respiratory Disease,Xinqiao Hospital,The Army Medical University(Third Military Medical University),400037 Chongqing,China;Department of Emergency Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Geriatric Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Immunology,School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Laboratory Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Hubei Key Laboratory of Embryonic Stem Cell Research,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Neurology,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China
Is oxygen therapy beneficial for normoxemic patients with acute heart failure? A propensity score matched study
Yue Yu;Ren-Qi Yao;Yu-Feng Zhang;Su-Yu Wang;Wang Xi;Jun-Nan Wang;Xiao-Yi Huang;Yong-Ming Yao;Zhi-Nong Wang-Department of Cardiothoracic Surgery,Changzheng Hospital,Naval Medical University,415 Fengyang Road,Huangpu District,Shanghai 200003,China;Trauma Research Center,Fourth Medical Center and Medical Innovation Research Department of the Chinese PLA General Hospital,51 Fucheng Road,Haidian District,Beijing 100048,China;Department of Burn Surgery,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Medical Research Center of War Injuries and Trauma,Changzheng Hospital,Naval Medical University,Shanghai 200003,China;Department of Pathology,Changhai Hospital,Naval Medical University,Shanghai 200433,China
N6?methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance
Xian Lin;Feng Wang;Jian Chen;Jing Liu;Yi?Bin Lin;Li Li;Chuan?Ben Chen;Qin Xu-Departments of Gynecology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Department of Radiation Oncology,Fujian Cancer Hospital and Fujian Medical University Cancer Hospital,Fujian Medical University,Fuzhou 350014,China;Shenzhen Key Laboratory of Immunity and Inflammatory Diseases,Peking University Shenzhen Hospital,Shenzhen Peking University?the Hong Kong University of Science and Technology Medical Center,Shenzhen 518036,Guangdong,China;Outpatient Department,Fujian Hospital of People's Armed Police,Fujian Medical University,Fuzhou 350014,China
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
Qiong Wang;Zean Li;Jin Yang;Shirong Peng;Qianghua Zhou;Kai Yao;Wenli Cai;Zhongqiu Xie;Fujun Qin;Hui Li;Xu Chen;Kaiwen Li;Hai Huang-Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Pathology,School of Medicine,University of Virginia,Charlottesville,VA 22908,USA;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Radiation Oncology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Urology,Sun Yat-sen University Cancer Center,Guangzhou 510060,China;Department of Radiology,Massachusetts General Hospital,Harvard Medical School,Boston,MA 02114,USA;Department of Urology,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China
Comparison of outcomes between immediate implant- based and autologous reconstruction: 15-year, single-center experience in a propensity score-matched Chinese cohort
Shanshan He;Bowen Ding;Gang Li;Yubei Huang;Chunyong Han;Jingyan Sun;Qingfeng Huang;Jing Liu;Zhuming Yin;Shu Wang;Jian Yin-Department of Breast Reconstruction,Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Sino-Russian Joint Research Center for Oncoplastic Breast Surgery,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,University College London,London WC1N 1AX,UK;Department of Cancer Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。